查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600197

預填充式注射器市場：按設計、產品類型、治療方法、應用分類 - 2025-2030 年全球預測

Prefilled Syringes Market by Design, Product Type, Therapeutic, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年預填充式注射器市場規模為139.2億美元，預計2024年將達到149.1億美元，複合年成長率為7.63%，2030年將達232.9億美元。

預填充式注射器市場是製藥和醫療保健產業中一個快速成長的領域，其定義是使用預充有特定劑量以便於給藥的注射器。該市場是由更有效率、更安全、更方便地輸送注射藥物（特別是疫苗、生技藥品和急救藥物）的需求所推動的。預填充式注射器在腫瘤學、糖尿病和心血管疾病等治療領域有著重要的應用，同時因降低污染風險和精確的藥物傳遞而受到青睞。生技藥品的進步和患者對自我給藥的偏好的增加正在推動對預填充式注射器的需求。關鍵的成長要素包括慢性病的增加、生物製藥行業的擴張以及以患者為中心的醫療保健解決方案日益成長的需求。市場機會主要存在於解決生物製藥複雜性的雙腔室和自動注射器等創新中。挑戰包括注射器與多種生技藥品的兼容性以及潛在的監管障礙。這些因素需要加強材料科學的研究，以開發與更精緻的藥物相容的注射器，同時保持無菌和完整性。此外，人們越來越關注永續性，並鼓勵環保材料和可回收組件的創新，以減少對環境的影響。該市場競爭激烈，成熟的製藥公司和專業生物技術公司共同推動市場。為了利用新的商機，公司應投資於更具永續和生物相容性的注射器設計的研發，並加強新興市場銷售管道的策略夥伴關係。不斷將患者回饋納入產品開發有助於確保符合不斷變化的醫療保健需求和監管標準。

主要市場統計
基準年[2023] 139.2億美元
預測年份 [2024] 149.1億美元
預測年份 [2030] 232.9億美元
複合年成長率（%） 7.63%

市場動態：揭示快速發展的預填充式注射器市場的關鍵市場洞察

供需的動態交互作用正在改變預填充式注射器市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 自我護理設備的普及數位化的進步
    • 學名藥快速成長
    • 增加支出以開發高效的醫療基礎設施
  • 市場限制因素
    • 缺乏具有整合安全功能的預填充式注射器
  • 市場機會
    • 新興國家醫療保健基礎設施的成長
    • 更多採用穿戴式藥物傳輸技術
  • 市場挑戰
    • 具有成本效益的替代方案的可用性

波特五力：駕馭預填充式注射器市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解預填充式注射器市場的外部影響

外部宏觀環境因素在塑造預填充式注射器市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解預填充式注射器市場的競爭狀況

對預填充式注射器市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣預填充式注射器市場供應商績效評估

FPNV定位矩陣是評估預填充式注射器市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了預填充式注射器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，預填充式注射器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大自我護理設備和數位化的引進
      • 學名藥快速成長
      • 增加開發高效能醫療基礎設施的支出
    • 抑制因素
      • 缺乏具有整合安全功能的預填充式注射器
    • 機會
      • 擴大新興國家的醫療基礎設施
      • 更多採用穿戴式藥物傳輸技術
    • 任務
      • 具有成本效益的替代方案的可用性
  • 市場區隔分析
    • 治療類別：擴大預填充式注射器在不同類別中的使用，強調了它們在促進更好的治療結果方面的作用。
    • 應用：適用於各種醫療狀況的預填充式注射器對於了解市場潛力和成長動力至關重要。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章預填充式注射器市場：設計

  • 客製化預填充式注射器
  • 雙腔室預填充式注射器
  • 單室預填充式注射器

第7章預填充式注射器市場：依產品類型

  • 玻璃預灌封注射器
  • 塑膠預灌封注射器

第8章預填充式注射器市場治療

  • 用於關節炎的預填充式注射器
  • 肝素填充注射器
  • 胰島素預填充式注射器
  • PCSK9抑制劑預填充式注射器
  • 疫苗預灌封注射器

第9章預填充式注射器市場：依應用分類

  • 過敏反應
  • 癌症
  • 糖尿病
  • 眼科
  • 類風濕性關節炎
  • 血栓症

第10章 北美和南美預填充式注射器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太預填充式注射器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲預填充式注射器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Bora Pharmaceuticals 收購 Emergent BioSolutions 的巴爾的摩工廠，以擴大北美業務並加強預填充式注射器生產
    • Schott Pharma 與 Col Medical Systems 合作，透過創新的預填充式注射器解決方案增強生物製藥藥物輸送和市場佔有率
    • ROVI 透過專注於便利性、安全性和永續性的新預填充式注射器製造協議提高了市場佔有率和收益。
    • 肖特製藥擴大美國業務，透過新的預填充式注射器工廠提高產能和市場滲透率
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • AptarGroup, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Catalent, Inc. by Novo Holdings A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • Mylan NV by Viatris Inc.
  • Nipro Europe Group Companies
  • Novartis AG
  • Pfizer, Inc.
  • Samsung Bioepis
  • Sanofi
  • SCHOTT Pharma
  • Shandong Weigao Group Medical Polymer Company Limited
  • SHL Medical AG
  • Stevanato Group
  • Terumo Medical Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
Product Code: MRR-030EE48515C9

The Prefilled Syringes Market was valued at USD 13.92 billion in 2023, expected to reach USD 14.91 billion in 2024, and is projected to grow at a CAGR of 7.63%, to USD 23.29 billion by 2030.

The prefilled syringes market is a rapidly growing segment within the pharmaceutical and healthcare industry, defined by the use of syringes that are pre-packed with a specific dosage of medication, allowing for easy administration. This market is driven by the necessity for more efficient, safe, and convenient delivery of injectable drugs, particularly vaccines, biologics, and emergency medications. Prefilled syringes find critical applications in therapeutic areas such as oncology, diabetes, and cardiovascular diseases, while also being favored for their reduced risk of contamination and precise drug delivery. Advances in biologics and a rising preference for self-administration among patients propel the demand for prefilled syringes. Key growth factors include the increasing number of chronic diseases, expanding biopharmaceutical sector, and mounting need for patient-centric healthcare solutions. Market opportunities are present in technological innovations like dual-chamber and auto-injectable syringes, predominantly addressing the complexities of biologic drug formulations. Limitations include challenges in achieving syringe compatibility with a wide range of biologics and potential regulatory hurdles. These factors necessitate enhanced research in materials science to develop syringes that are more compatible with sensitive drugs while maintaining sterility and integrity. Furthermore, sustainability is a growing concern, recommending innovations in eco-friendly materials and recyclable components to mitigate environmental impact. The nature of the market is progressively competitive, driven by both established pharmaceutical companies and specialized biotech firms. To capitalize on emerging opportunities, businesses should invest in R&D for more sustainable and biocompatible syringe designs and strengthen strategic partnerships for distribution channels in emerging markets. Continuous patient feedback integration into product development can ensure better adherence to evolving healthcare demands and regulatory standards.

KEY MARKET STATISTICS
Base Year [2023] USD 13.92 billion
Estimated Year [2024] USD 14.91 billion
Forecast Year [2030] USD 23.29 billion
CAGR (%) 7.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Prefilled Syringes Market

The Prefilled Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of self-care devices and digitalization
    • Rapid growth in generic products
    • Rising expenditure on development of efficient healthcare infrastructure
  • Market Restraints
    • Dearth of prefilled syringes with integrated safety features
  • Market Opportunities
    • Growing healthcare infrastructure across emerging countries
    • Increasing adoption of wearable drug delivery technologies
  • Market Challenges
    • Availability of cost effective alternatives

Porter's Five Forces: A Strategic Tool for Navigating the Prefilled Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Prefilled Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Prefilled Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Prefilled Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Prefilled Syringes Market

A detailed market share analysis in the Prefilled Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Prefilled Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Prefilled Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Prefilled Syringes Market

A strategic analysis of the Prefilled Syringes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Prefilled Syringes Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AptarGroup, Inc., Baxter International, Inc., Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Gerresheimer AG, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. by Johnson & Johnson, Mylan N.V. by Viatris Inc., Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., Samsung Bioepis, Sanofi, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Prefilled Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Design, market is studied across Customized Prefilled Syringes, Dual-Chamber Prefilled Syringes, and Single-Chamber Prefilled Syringes.
  • Based on Product Type, market is studied across Glass Pre Filled Syringes and Plastic Pre Filled Syringes.
  • Based on Therapeutic, market is studied across Arthritis Pre Filled Syringes, Heparin Pre Filled Syringes, Insulin Pre Filled Syringes, PCSK9 Inhibitor Pre Filled Syringes, and Vaccine Pre Filled Syringes.
  • Based on Application, market is studied across Anaphylaxis, Cancer, Diabetes, Ophthalmology, Rheumatoid Arthritis, and Thrombosis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of self-care devices and digitalization
      • 5.1.1.2. Rapid growth in generic products
      • 5.1.1.3. Rising expenditure on development of efficient healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of prefilled syringes with integrated safety features
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing healthcare infrastructure across emerging countries
      • 5.1.3.2. Increasing adoption of wearable drug delivery technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of cost effective alternatives
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Therapeutic Category: Expanding use of prefilled syringes across various categories underscores their role in fostering better therapeutic outcomes
    • 5.2.2. Application: Prefilled syringes across various medical conditions is vital to understanding their market potential and growth drivers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Prefilled Syringes Market, by Design

  • 6.1. Introduction
  • 6.2. Customized Prefilled Syringes
  • 6.3. Dual-Chamber Prefilled Syringes
  • 6.4. Single-Chamber Prefilled Syringes

7. Prefilled Syringes Market, by Product Type

  • 7.1. Introduction
  • 7.2. Glass Pre Filled Syringes
  • 7.3. Plastic Pre Filled Syringes

8. Prefilled Syringes Market, by Therapeutic

  • 8.1. Introduction
  • 8.2. Arthritis Pre Filled Syringes
  • 8.3. Heparin Pre Filled Syringes
  • 8.4. Insulin Pre Filled Syringes
  • 8.5. PCSK9 Inhibitor Pre Filled Syringes
  • 8.6. Vaccine Pre Filled Syringes

9. Prefilled Syringes Market, by Application

  • 9.1. Introduction
  • 9.2. Anaphylaxis
  • 9.3. Cancer
  • 9.4. Diabetes
  • 9.5. Ophthalmology
  • 9.6. Rheumatoid Arthritis
  • 9.7. Thrombosis

10. Americas Prefilled Syringes Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Prefilled Syringes Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Prefilled Syringes Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bora Pharmaceuticals acquires Baltimore facility from Emergent BioSolutions to expand North American footprint and enhance prefilled syringe production
    • 13.3.2. SCHOTT Pharma and Koru Medical Systems partner to enhance drug delivery, market share in biologics with innovative prefilled syringe solutions
    • 13.3.3. ROVI to enhance market presence and revenue with new pre-filled syringe manufacturing agreement, focusing on convenience, safety, and sustainability
    • 13.3.4. Schott Pharma expands U.S. operations with new prefillable syringe facility boosting production capacity and market penetration
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AptarGroup, Inc.
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Boehringer Ingelheim Pharmaceuticals, Inc
  • 6. Catalent, Inc. by Novo Holdings A/S
  • 7. Eli Lilly and Company
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Fresenius Kabi AG
  • 10. Gerresheimer AG
  • 11. GlaxoSmithKline plc
  • 12. Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • 13. Mylan N.V. by Viatris Inc.
  • 14. Nipro Europe Group Companies
  • 15. Novartis AG
  • 16. Pfizer, Inc.
  • 17. Samsung Bioepis
  • 18. Sanofi
  • 19. SCHOTT Pharma
  • 20. Shandong Weigao Group Medical Polymer Company Limited
  • 21. SHL Medical AG
  • 22. Stevanato Group
  • 23. Terumo Medical Corporation
  • 24. Teva Pharmaceutical Industries Ltd.
  • 25. West Pharmaceutical Services, Inc.
  • 26. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. PREFILLED SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 2. PREFILLED SYRINGES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PREFILLED SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PREFILLED SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GLASS PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ARTHRITIS PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY HEPARIN PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY INSULIN PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PCSK9 INHIBITOR PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VACCINE PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023